Dr. Bing Hu | Medicine | Best Researcher Award
Hearing Research at Shenzhen University, China
Dr. Bing Hu is a senior clinical otolaryngologist and postdoctoral fellow in Clinical Medicine at Sun Yat-sen University. With over 16 years of experience in the diagnosis, treatment, and surgical management of ENT (Ear, Nose, and Throat) diseases, Dr. Hu brings deep clinical knowledge and research expertise. He has been jointly trained by Xiangya Medical College and Case Western Reserve University (USA), and has held a visiting scholar position at the renowned Cleveland Clinic. His clinical proficiency, combined with an active role in medical research, has resulted in numerous national-level project participations and over 10 peer-reviewed publications.
Publication Profileย
Educational Background ๐
-
Doctor of Medicine (M.D.)
Joint program by Case Western Reserve University (USA) & Xiangya Medical College (China) -
Ph.D. in Clinical Medicine
Sun Yat-sen University, China -
Postdoctoral Fellowship in Clinical Medicine
Sun Yat-sen University -
Clinical Training
-
Eye, Ear, Nose, and Throat Hospital, Fudan University
-
First Affiliated Hospital, Sun Yat-sen University
-
Professional Experience ๐ผ
-
Postdoctoral Fellow
Department of Clinical Medicine, Sun Yat-sen University -
ENT Specialist and Surgeon
Department of Otolaryngology โ Head and Neck Surgery, Shenzhen Secondary Hospital & First Affiliated Hospital of Shenzhen University -
Visiting Scholar
Cleveland Clinic, USA -
Clinical Doctor (16 years experience)
-
Expertise in diagnosis and surgical management of ENT diseases
-
Practiced at multiple tier-one hospitals in China
-
Research Interests ๐ฌ
-
Otolaryngologic Diseases (ENT)
-
Minimally Invasive Endoscopic Surgery
-
Inflammatory and Infectious Diseases of the ENT System
-
Pediatric ENT Conditions (Adenoid Hypertrophy, Tonsillitis)
-
Surgical Management of Sinusitis, Rhinitis, Epistaxis
-
Clinical Outcomes and Patient-Centered Treatment Optimization
Awards and Honors๐โจ
-
National Scholarship for Scholarly Exchange
Awarded for outstanding performance in international medical training and research -
Visiting Scholar Recognition
Cleveland Clinic โ Recognized for advanced clinical research contributions -
Contributor and Investigator in Multiple Funded Projects
At national, provincial, and municipal levels
Conclusion๐
Dr. Bing Hu exemplifies the integration of clinical excellence with academic rigor. His dual training in China and the United States, along with his extensive surgical expertise and research involvement, position him as a leading figure in the field of otolaryngology. His continued work at the intersection of patient care and innovation ensures his lasting impact on ENT practice and education in China and beyond.
Publications ๐
-
๐ 3D UNet-based Abdominal Organ Automatic Segmentation Model using Image Denoising and Point Cloud Fusion
๐ฐ Alexandria Engineering Journal | ๐ 2025
๐จโ๐ป Authors: Xue J., Hu B.
๐ Open Access -
๐งฌ Toe1 Promotes Proliferation and Differentiation of Neural Progenitor Cells
๐ฐ Heliyon | ๐ 2024
๐จโ๐ป Authors: Deng T., Wu X., Wang Y., Fan X., Hu B.
๐ Cited: 1 -
๐งโโ๏ธ BRCA1 Promotes Repair of DNA Damage in Cochlear Hair Cells and Prevents Hearing Loss
๐ฐ The Journal of Neuroscience | ๐ 2024-09-03
๐ DOI: 10.1523/jneurosci.0132-24.2024
๐จโ๐ป Authors: Jiang W., Wang G., Bai F., Hu B., Xu Y., et al. -
๐ง Advancements in Prevention and Intervention of Sensorineural Hearing Loss
๐ฐ Therapeutic Advances in Chronic Disease | ๐ 2022-06-27
๐ DOI: 10.1177/20406223221104987
๐จโ๐ป Authors: Hong, Hu B., Jiang G.
๐ PMC: PMC9243368 -
๐ฟ Novel Application of Eupatilin for Effectively Attenuating Cisplatin-Induced Auditory Hair Cell Death via Mitochondrial Apoptosis Pathway
๐ฐ Oxidative Medicine and Cellular Longevity | ๐ 2022-01-17
๐ DOI: 10.1155/2022/1090034
๐ PMC: PMC8786471 -
๐ฉบ Effectiveness of Salvage Intratympanic Dexamethasone Treatment for Refractory Sudden Sensorineural Hearing Loss Classified by Audiogram Patterns
๐ฐ Acta Oto-Laryngologica | ๐ 2021-02-27
๐ DOI: 10.1080/00016489.2021.1889029 -
๐ Autophagy Impairment as a Key Feature for Acetaminophen-Induced Ototoxicity
๐ฐ Cell Death & Disease | ๐ 2021-01-04
๐ DOI: 10.1038/s41419-020-03328-6
๐ PMC: PMC7791066 -
๐ฌ Liproxstatin-1 Protects Hair Cell-Like HEI-OC1 Cells and Cochlear Hair Cells against Neomycin Ototoxicity
๐ฐ Oxidative Medicine and Cellular Longevity | ๐ 2020-12-01
๐ DOI: 10.1155/2020/1782659
๐ PMC: PMC7725559 -
โ๏ธ Ferrostatin-1 Protects Auditory Hair Cells from Cisplatin-Induced Ototoxicity In Vitro and In Vivo
๐ฐ Biochemical and Biophysical Research Communications | ๐ 2020-10-24
๐ DOI: 10.1016/j.bbrc.2020.10.019 -
๐ฑ Otoprotective Effects of Stephania tetrandra S. Moore Herb Isolate against Acoustic Trauma
๐ฐ Journal of the Association for Research in Otolaryngology (JARO) | ๐ 2018-09-05
๐ DOI: 10.1007/s10162-018-00690-3
๐ PMC: PMC6249158 -
๐งฌ Atoh1: Landscape for Inner Ear Cell Regeneration
๐ฐ Current Gene Therapy | ๐ 2014
๐ DOI: 10.2174/1566523214666140310143407